Refine
Document Type
- Article (6)
Language
- English (6)
Has Fulltext
- yes (6)
Is part of the Bibliography
- no (6)
Keywords
- parasitoid wasps (3)
- 5-lipoxygenase (1)
- Central Europe (1)
- DNA barcoding (1)
- Digitization (1)
- Leptura aurulenta (1)
- Michael acceptor (1)
- NF-κB (1)
- Nrf-2 (1)
- Palearctic (1)
Institute
- Medizin (2)
Taxonomic history and review of the Förster genera of Platygastridae (Hymenoptera: Platygastroidea)
(2023)
Platygastridae is a ʻdark taxonʼ, with many genera and species in dire need of professional attention. The taxonomic impediment is especially severe in the Palearctic Platygastrinae due to the abundance of names with vague concepts. Historical descriptions and their associated type material must be examined and clarified before further revisionary work can occur. Arnold Förster described 18 genera of Platygastridae, most of which represent distinct and recognizable lineages. The present study reviews their taxonomic history, providing diagnostic remarks, English translations, and illustrations of important specimens from the Förster collection in the Natural History Museum Vienna. The collection also includes original exemplar specimens of European species whose types have been lost. Neotypes and lectotypes are designated from this material to improve nomenclatural stability in the group. Neotypes are designated for Amblyaspis forticornis (Nees, 1834), Isocybus grandis (Nees, 1834), Platygaster striolata Nees, 1834, and Trichacis tristis (Nees, 1834). Lectotypes are designated for Leptacis spinigera (Nees, 1834) comb. nov. and for Platygaster corvina Förster, 1861, with Platygaster henkvlugi Buhl, 1996 treated as a junior synonym. Platygaster mutica Nees, 1834 stat. rev., nomen dubium, is transferred from Synopeas.
Platystasius transversus (Thomson) (Hymenoptera: Platygastridae) is a rarely collected egg parasitoid of Leptura aurulenta Fabricius (Coleoptera: Cerambycidae). Four female specimens were found in Germany, a new country record for the genus and species. Illustrations, DNA barcodes, and an updated distribution are provided. We review its taxonomic history, biology, and ecological associations.
Endogenous nitro-fatty acids (NFA) are potent electrophilic lipid mediators that exert biological effects in vitro and in vivo via selective covalent modification of thiol-containing target proteins. The cytoprotective, anti-inflammatory, and anti-tumorigenic effects of NFA in animal models of disease caused by targeted protein nitroalkylation are a valuable basis for the development of future anti-phlogistic and anti-neoplastic drugs. Considering the complexity of diseases and accompanying comorbidities there is an urgent need for clinically effective multifunctional drugs. NFA are composed of a fatty acid backbone containing a nitroalkene moiety triggering Michael addition reactions. However, less is known about the target-specific structure–activity relationships and selectivities comparing different NFA targets. Therefore, we analyzed 15 NFA derivatives and compared them with the lead structure 9-nitro-oleic acid (9NOA) in terms of their effect on NF-κB (nuclear factor kappa B) signaling inhibition, induction of Nrf-2 (nuclear factor erythroid 2-related factor 2) gene expression, sEH (soluble epoxide hydrolase), LO (lipoxygenase), and COX-2 (cyclooxygenase-2) inhibition, and their cytotoxic effects on colorectal cancer cells. Minor modifications of the Michael acceptor position and variation of the chain length led to drugs showing increased target preference or enhanced multi-targeting, partly with higher potency than 9NOA. This study is a significant step forward to better understanding the biology of NFA and their enormous potential as scaffolds for designing future anti-inflammatory drugs.
Nitro fatty acids (NFAs) are endogenously generated lipid mediators deriving from reactions of unsaturated electrophilic fatty acids with reactive nitrogen species. Furthermore, Mediterranean diets can be a source of NFA. These highly electrophilic fatty acids can undergo Michael addition reaction with cysteine residues, leading to post-translational modifications (PTM) of selected regulatory proteins. Such modifications are capable of changing target protein function during cell signaling or in biosynthetic pathways. NFA target proteins include the peroxisome proliferator-activated receptor γ (PPAR-γ), the pro-inflammatory and tumorigenic nuclear factor-κB (NF-κB) signaling pathway, the pro-inflammatory 5-lipoxygenases (5-LO) biosynthesis pathway as well as soluble epoxide hydrolase (sEH), which is essentially involved in the regulation of vascular tone. In several animal models of inflammation and cancer, the therapeutic efficacy of well-tolerated NFA has been demonstrated. This has already led to clinical phase II studies investigating possible therapeutic effects of NFA in subjects with pulmonary arterial hypertension. Albeit Michael acceptors feature a broad spectrum of bioactivity, they have for a rather long time been avoided as drug candidates owing to their presumed unselective reactivity and toxicity. However, targeted covalent modification of regulatory proteins by Michael acceptors became recognized as a promising approach to drug discovery with the recent FDA approvals of the cancer therapeutics, afatanib (2013), ibrutinib (2013), and osimertinib (2015). Furthermore, the Michael acceptor, neratinib, a dual inhibitor of the human epidermal growth factor receptor 2 and epidermal growth factor receptor, was recently approved by the FDA (2017) and by the EMA (2018) for the treatment of breast cancer. Finally, a number of further Michael acceptor drug candidates are currently under clinical investigation for pharmacotherapy of inflammation and cancer. In this review, we focus on the pharmacology of NFA and other Michael acceptor drugs, summarizing their potential as an emerging class of future antiphlogistics and adjuvant in tumor therapeutics.
As insect decline threatens the fauna of Central Europe, “dark taxa” present an obstacle to understanding biodiversity loss. The superfamily Platygastroidea is a dark taxon, with many superficial descriptions requiring examination of type material to characterize and revise species and genera. The Natural History Museum Vienna (Naturhistorisches Museum Wien) is arguably the most important historical collection of Platygastroidea in Central Europe. Type specimens from 85 species in 21 genera and three families are here catalogued and photographically illustrated, including previously undocumented types described by Förster, Kieffer, Nees von Esenbeck, and Ratzeburg. Lectotypes are designated for Anteris bicolor Kieffer, Anteris simulans Kieffer, Hadronotus laticeps Kieffer, Leptacis foersteri Kieffer, Plastogryon investis Kieffer, Plastogryon sagax Kieffer, Prophanurus mayri Kieffer, and Telenomus laeviceps Förster. Trissolcus schimitsheki (Szelényi) syn. nov. is treated as a junior synonym of Trissolcus scutellaris (Thomson) and Telenomus nomas Förster syn. nov. is treated as a junior synonym of Trissolcus semistriatus (Nees). Baeus maculatus (Förster) comb. nov. is transferred from Telenomus. Historical, taxonomic, and curatorial remarks are included, providing an essential foundation for revisionary work on the Platygastroidea of Central Europe and beyond.
High resolution images are provided for type specimens of Platygastroidea (Hymenoptera: Apocrita) in the Hope Entomological Collections, Oxford University. We formally resurrect Trissoscelio Kieffer revised status to accommodate T. bifasciata (Dodd) new combination, T. indica (Mani) new combination, T. nigriceps Kieffer revised combination, T. ruficeps Kieffer revised combination, and T. punctaticeps Kieffer revised combination. Paridris subplana (Dodd) new combination is transferred from Sceliacantha Dodd to Paridris Kieffer and treated as a senior synonym of P. coorgensis Sharma.
ZooBank registration. urn:lsid:zoobank.org:pub:EB97FE10-B01D-4D45-AF6E-D247ED0040BE